Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks

Objective: To evaluate the continued safety and durability of clinical response in patients with ankylosing spondylitis receiving etanercept. Methods: 277 patients who had participated in a previous randomised, double blind, placebo controlled 24 week trial were eligible to continue in this open lab...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Davis, J, van der Heijde, D M, Braun, J, Dougados, M, Cush, J, Clegg, D, Inman, R, Kivitz, A, Zhou, L, Solinger, A, Tsuji, W
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2005
Pynciau:
Extended Report
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC1755272/
https://ncbi.nlm.nih.gov/pubmed/15843448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2004.035105
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg